Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 21.25% is 254% above its 5-year average of 6.00%, near the high end of its 5-year range (-1451.61%–45.60%).
43.37% above its 12-month average of 14.82%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 31.24%.
NET PROFIT MARGIN
21.25%
NET PROFIT MARGIN AVG TTM
14.82%
NET PROFIT MARGIN AVG 3Y
2.51%
NET PROFIT MARGIN AVG 5Y
6.00%
NET PROFIT MARGIN AVG 10Y
-46.51%
NET PROFIT MARGIN AVG 15Y
-60.80%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+43.37%
CURRENT VS 3Y AVG
+745.46%
CURRENT VS 5Y AVG
+254.43%
CURRENT VS 10Y AVG
+145.69%
CURRENT VS 15Y AVG
+134.95%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+8273.08%
vs the sector median at left
Nutex Health, Inc.
Market Cap
$1.52B
Net Profit Margin
21.25%
TTM Avg
14.82%
3Y Avg
2.51%
5Y Avg
6.00%
Market Cap
$1.50B
Net Profit Margin
12.02%
TTM Avg
-7.78%
3Y Avg
-15.24%
5Y Avg
-11964.64%
Market Cap
$1.54B
Net Profit Margin
-87.60%
TTM Avg
-755.85%
3Y Avg
-377.93%
5Y Avg
-1051.76%
Market Cap
$1.54B
Net Profit Margin
80.56%
TTM Avg
35.15%
3Y Avg
48.19%
5Y Avg
54.54%
Market Cap
$1.48B
Net Profit Margin
6.57%
TTM Avg
5.15%
3Y Avg
3.47%
5Y Avg
4.27%
Market Cap
$1.47B
Net Profit Margin
-685.80%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.57B
Net Profit Margin
-753.60%
TTM Avg
-123.57%
3Y Avg
-563.59%
5Y Avg
-375.72%
Market Cap
$1.46B
Net Profit Margin
-667.95%
TTM Avg
15.59%
3Y Avg
7.79%
5Y Avg
7.79%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nutex Health, Inc. (NUTX) | $1.52B | 21.25% | 14.82% | 2.51% | 6.00% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 12.02% | -7.78% | -15.24% | -11964.64% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | -87.60% | -755.85% | -377.93% | -1051.76% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 80.56% | 35.15% | 48.19% | 54.54% |
| Phibro Animal Health Corporation (PAHC)vs › | $1.48B | 6.57% | 5.15% | 3.47% | 4.27% |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.47B | -685.80% | 0.00% | 0.00% | 0.00% |
| GH Research PLC (GHRS)vs › | $1.47B | 0.00% | 0.00% | 0.00% | 0.00% |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | -753.60% | -123.57% | -563.59% | -375.72% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | -667.95% | 15.59% | 7.79% | 7.79% |
| Certara, Inc. (CERT)vs › | $1.45B | -16.75% | -1.75% | -3.69% | -6.61% |
Operating Margin
31.5%
Net Profit Margin
21.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 31.24% |
| 2026-03-31 | 21.62% |
| 2025-12-31 | 7.80% |
| 2025-09-30 | 20.70% |
| 2025-06-30 | -7.25% |
| 2025-03-31 | 6.91% |
| 2024-12-31 | 23.95% |
| 2024-09-30 | -11.15% |
| 2024-06-30 | -0.48% |
| 2024-03-31 | -0.54% |
| 2023-12-31 | -45.38% |
| 2023-09-30 | -8.84% |
| 2023-06-30 | -5.90% |
| 2023-03-31 | -9.14% |
| 2022-12-31 | -8.23% |
| 2022-09-30 | -1451.61% |
| 2022-06-30 | -33.22% |
| 2022-03-31 | 27.10% |
| 2021-12-31 | 22.05% |
| 2021-09-30 | 45.60% |
| 2021-06-30 | 43.08% |
| 2021-03-31 | -220.65% |
| 2020-12-31 | 37.93% |
| 2020-09-30 | 501.71% |
| 2020-06-30 | 60.04% |
| 2020-03-31 | -271.62% |
| 2019-12-31 | -416.63% |
| 2019-09-30 | -440.70% |
| 2019-06-30 | -366.19% |
| 2019-03-31 | -456.39% |
| 2018-12-31 | -2925.06% |
| 2018-09-30 | -2694.71% |
| 2018-06-30 | -19491.33% |
| 2018-03-31 | -14552.31% |
| 2017-12-31 | 30936.43% |
| 2017-09-30 | 23457.25% |
| 2017-06-30 | -35848.75% |
| 2017-03-31 | -5564.92% |
| 2016-09-30 | 27.16% |
| 2016-06-30 | -16.28% |
| 2016-03-31 | -59.16% |
| 2011-12-31 | -21.69% |
| 2011-09-30 | -25.52% |
| 2011-06-30 | -17.49% |
| 2011-03-31 | 8.40% |
| 2010-12-31 | -72.81% |
| 2010-09-30 | 72.57% |
| 2010-06-30 | 59.76% |
| 2010-03-31 | 93.33% |
| 2009-12-31 | 0.00% |
